HALEIGH GRIFFITH: Open Payments
NPI 1942934088 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$251 in 11 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $97 · 2025 $251
Food & beverage: $251
| Company | Payments | Amount |
|---|---|---|
| RECORDATI_RARE_DISEASES_INC. | 2 | $57 |
| Sanara MedTech Inc. | 2 | $53 |
| SI-BONE, INC. | 2 | $47 |
| Alexion Pharmaceuticals, Inc. | 1 | $20 |
| Integra LifeSciences Corporation | 1 | $20 |
| PolyNovo North America LLC | 1 | $19 |
| Solventum Corporation | 1 | $18 |
| Neurocrine BioSciences, Inc. | 1 | $17 |
Products named: ISTURISA, CellerateRX, STRENSIQ, Integra, NOVOSORB BTM, PREVENA, CRENESSITY.
Industry payments across NE — which companies pay providers there.
